Source: FinanzNachrichten

Leukos Biotech: AOP Orphan Pharmaceuticals GmbH: Cancer Therapy: AOP Health Investigates a New Approach Targeting Cancer Stem Cells

AOP Orphan Pharmaceuticals GmbH (AOP Health) in collaboration with Leukos Biotech has achieved a key milestone. The first patient was included in the phase I clinical trial SERONCO-1, in which a s...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Enrique Llaudet Carles's photo - CEO of Leukos Biotech

CEO

Enrique Llaudet Carles

CEO Approval Rating

70/100

Read more